Posters
« Back
Neuroimaging in Dementia: A Brief Review
EP34247
Poster Title: Neuroimaging in Dementia: A Brief Review
Submitted on 27 Oct 2020
Author(s): Dr Dipanjan Banerjee, Dr Abilash Muralidharan, Dr Abdul Rub Hakim Mohammed and Dr Bilal Haider Malik
Affiliations: CIBNP
Poster Views: 408
View poster »


Poster Information
Abstract: Dementia is a clinical syndrome that manifests itself with impairment in cognitive functions owing to various neurodegenerative etiologies causing severe disability in the older population. Although the diagnosis is largely dependent on clinical examination, biomarkers can significantly aid in early diagnosis of dementia, especially in those without any clinical evidence of neurocognitive impairment. These biomarkers can be discovered in cerebrospinal fluid (CSF) or can be assessed by neuroimaging. Our goal was to discuss and assess the role of different neuroimaging techniques in the early diagnosis of relatively common etiologies of dementia. We used PubMed as search engines to look for helpful articles; most of the sources used were peer reviewed. We discussed the utility of various neuroimaging techniques, such CT, MRI, positron emission tomography (PET) scan, and single-photon emission computed tomography (SPECT), in the diagnosis of dementia. We concluded that various modern neuroimaging techniques prove to be very helpful in early identification, diagnosis, and differentiation between subtypes. However, the actual clinical utility of these tests in terms of their cost-effectivity and availability remains to be seen. Ongoing research is required to further develop biomarkers for early identification and monitor the progression of different etiologies of dementia.Summary: A review article summarising the role of neuroimaging in the early and apt diagnosis of dementia.References: 1. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease. Drzezga A, Grimmer T, Henriksen G, et al. Neuroimage. 2008;39:619–633. [PubMed] [Google Scholar]
2. In vivo amyloid imaging with PET in frontotemporal dementia. Engler H, Santillo AF, Wang SX, et al. Eur J Nucl Med Mol Imaging. 2008;35:100–106. [PubMed] [Google Scholar]
3. A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review. Davison CM, O’Brien JT. Int J Geriatr Psychiatry. 2014;29:551–561. [PubMed] [Google Scholar]
4. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease. Foster NL, Heidebrink JL, Clark CM, et al. Brain. 2007;130:2616–2635. [PubMed] [Google Scholar]
5. Evaluation of the new consensus criteria for the diagnosis of primary progressive aphasia using fluorodeoxyglucose positron emission tomography. Matias-Guiu JA, Cabrera-Martín MN, García-Ramos R, et
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons